Experimental models of arteriogenesis: Differences and implications

Lab Animal

Volumn 35, Issue 2, 2006, Pages 36-44

  Hoefer, Imo E ^a   Van Royen, Niels ^b   Jost, Marco M ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BioVisioN AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL; ANIMAL DISEASE; ANIMAL MODEL; ARTERY; GROWTH, DEVELOPMENT AND AGING; HINDLIMB; METHODOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANGIOGRAPHY; ANIMALS; ARTERIES; HINDLIMB; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 33645081757     PISSN: 00937355     EISSN: 15484475     Source Type: Journal    
DOI: 10.1038/laban0206-36     Document Type: Review

References (66)

1. Risau, W. Mechanisms of angiogenesis. Nature 386(6626), 671-674 (1997).
2. Risau, W. & Flamme, I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91 (1995).
3. Flamme, I., Frolich, T. & Risau, W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 173(2), 206-210 (1997).
4. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967 (1997).
5. Urbich, C. & Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95(4), 343-353 (2004).
6. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6(4), 389-395 (2000).
7. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285(21), 1182-1186 (1971).
8. Folkman, J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175(3), 409-416 (1972).
9. Folkman, J. Tumor angiogenesis: a possible control point in tumor growth. Ann. Intern. Med. 82(1), 96-100. (1975).
10. Carmeliet, P. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394(6692), 485-490 (1998).
11. Henry, T. et al. Double blind, placebo controlled trial of recombinant human vascular endothelial growth factor: the VIVA trial. J. Am. Coll. Cardiol. 33(2: Supp A), 384 (1999).
12. Lower, R. Tractus de Corde (Elsevier, Amsterdam, 1669).
13. Longland, C.J. The collateral circulation of the limb. Ann. Roy. Coll. Surg. Engl. 13(3), 161-164 (1953).
14. Ito, W.D. et al. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am. J. Physiol. 273(3 Pt 2), H1255-H1265 (1997).
15. Deindl, E. et al. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89(9), 779-786 (2001).
16. Hoefer, I.E. et al. Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ. Res. 94(9), 1179-1185 (2004).
17. Scholz, D. et al. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res. 284(3), 415-423 (1996).
18. Scholz, D. et al. Ultrastructure and molecular histology of rabbit hindlimb collateral artery growth (arteriogenesis). Virchows Arch. 436(3), 257-270 (2000).
19. van Royen, N. et al. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization. Circulation 109(13), 1647-1652 (2004).
20. Arras, M. et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101(1), 40-50 (1998).
21. Ley, K., Allietta, M., Bullard, D.C. & Morgan, S. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83(3), 287-294 (1998).
22. Kukreti, S., Konstantopoulos, K., Smith, C.W. & McIntire, L.V. Molecular mechanisms of monocyte adhesion to interleukin-1β-stimulated endothelial cells under physiologic flow conditions. Blood 89(11), 4104-4111 (1997).
23. Languino, L.R. et al. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. USA 92(5), 1505-1509 (1995).
24. Morigi, M. et al. Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood 85(7), 1696-1703 (1995).
25. Cai, W. et al. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J. Mol. Cell. Cardiol. 32(6), 997-1011 (2000).
26. Cai, W.J. et al. Remodeling of the adventitia during coronary arteriogenesis. Am. J. Physiol. Heart Circ. Physiol. 284(1), H31-H40 (2003).
27. Scholz, D. et al. Early events in adaptive arteriogenesis. (Abstr.) J. Mol. Cell. Cardiol. 30(Suppl), A127 (1998).
28. Hoefer, I., van Royen, N., Buschmann, I., Piek, J. & Schaper, W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc. Res. 49(3), 609-617 (2001).
29. Pipp, F. et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler. Thromb. Vasc. Biol. 24(9), 1664-1668 (2004).
30. Unger, E.F. Experimental evaluation of coronary collateral development. Cardiovasc. Res. 49(3), 497-506 (2001).
31. Rentrop, K.P., Feit, F., Sherman, W. & Thornton, J.C. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation 80(5), 1166-1175 (1989).
32. Fuchs, S., Shou, M., Baffour, R., Epstein, S.E. & Kornowski, R. Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response. Coron. Artery Dis. 12(3), 173-178 (2001).
33. Heil, M. et al. Blood monocyte concentration is critical for the enhancement of collateral artery growth. Am. J. Physiol. Heart Circ. Physiol. 28(6), H2411-H2419 (2002).
34. Rivard, A. et al. Age-dependent impairment of angiogenesis. Circulation 99(1), 111-120 (1999).
35. Silvestre, J.S. et al. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 90(10), 1072-1079 (2002).
36. Schirmer, S.H. et al. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Cardiovasc. Res. 64(2), 356-364 (2004).
37. Wright, C.E., Angus, J.A. & Korner, P.I. Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hypertension 9(2), 122-131 (1987).
38. Buschmann, I.R. et al. Invasive and non-invasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease. Atherosclerosis 167(1), 33-43 (2003).
39. Voskuil, M. et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am. J. Physiol. Heart Circ. Physiol. 284(4), H1422-H1428 (2003).
40. Chien, G.L., Anselone, C.G., Davis, R.F. & Van Winkle, D.M. Fluorescent vs. radioactive microsphere measurement of regional myocardial blood flow. Cardiovasc. Res. 30(3), 405-412 (1995).
41. Van Oosterhout, M.F., Prinzen, F.W., Sakurada, S., Glenny, R.W. & Hales, J.R.S. Fluorescent microspheres are superior to radioactive microspheres in chronic blood flow measurements. Am. J. Physiol. 275(1 Pt 2), H110-H115 (1998).
42. Buckberg, G. Studies of regional coronary flow using radioactive microspheres. Ann. Thorac. Surg. 20(1), 46-51 (1975).
43. Bassingthwaighte, J.B. et al. Validity of microsphere depositions for regional myocardial flows. Am. J. Physiol. 253(1 Pt 2), H184-H193 (1987).
44. Glenny, R.W. Manual for Using Fluorescent Microspheres to Measure Regional Organ Perfusion (Fluorescent Microsphere Resource Center, Seattle, WA, 1996).
45. Yang, H.T., Ogilvie, R.W. & Terjung, R.L. Heparin increases exercise-induced collateral blood flow in rats with femoral artery ligation. Circ. Res. 76(3), 448-456 (1995).
46. Yang, H.T., Laughlin, M.H. & Terjung, R.L. Prior exercise training increases collateral-dependent blood flow in rats after acute femoral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 279(4), H1890-H1897 (2000).
47. Prior, B.M., Lloyd, P.G., Yang, H.T. & Terjung, R.L. Exercise-induced vascular remodeling. Exerc. Sport Sci. Rev. 31(1), 26-33 (2003).
48. Scholz, D. et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J. Mol. Cell. Cardiol. 34(7), 775-787 (2002).
49. Heil, M. et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ. Res. 94(5), 671-677 (2004).
50. Horvath, K.A. et al. Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. Ann. Thorac. Surg. 74(2), 481-486; discussion 487 (2002).
51. Wagner, S., Helisch, A., Bachmann, G. & Schaper, W. Time-of-flight quantitative measurements of blood flow in mouse hindlimbs. J. Magn. Reson. Imaging 19(4), 468-474 (2004).
52. Wagner, S., Helisch, A., Ziegelhoeffer, T., Bachmann, G. & Schaper, W. Magnetic resonance angiography of collateral vessels in a murine femoral artery ligation model. NMR Biomed. 17(1), 21-27 (2004).
53. Pipp, F. et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ. Res. 92(4), 378-385 (2003).
54. van Royen, N. et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ. Res. 92(2), 218-225 (2003).
55. -/- mice. J. Mol. Cell. Cardiol. 35(2), 177-184 (2003).
56. Ito, W.D. et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ. Res. 80(6), 829-837 (1997).
57. van Royen, N. et al. Exogenous application of transforming growth factor-β1 stimulates arteriogenesis in the peripheral circulation. FASEB J. 16(3), 432-434 (2002).
58. Grundmann, S. et al. Anti-tumor necrosis factor-α therapies attenuate adaptive arteriogenesis in the rabbit. Am. J. Physiol. Heart Circ. Physiol. 289(4), H1497-H1505 (2005).
59. Kopelman, D., Hirshhorn, G. & Hashmonai, M. Prevention of limb loss in critical ischaemia by arterialization of the superficial venous system: an experimental study in dogs. Cardiovasc. Surg. 6(4), 384-388 (1998).
60. Rakue, H. et al. Low-dose basic fibroblast growth factor and vascular endothelial growth factor for angiogenesis in canine acute hindlimb insufficiency. Jpn. Circ. J. 62(12), 933-939 (1998).
61. Herzog, S., Sager, H., Khmelevski, E., Deylig, A. & Ito, W.D. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am. J. Physiol. Heart Circ. Physiol. 283(5), H2012-H2020 (2002).
62. Yang, H.T., Deschenes, M.R., Ogilvie, R.W. & Terjung, R.L. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79(1), 62-69 (1996).
63. Kondo, T. & Watanabe, Y. A heritable hyperlipemic rabbit [in Japanese]. Jikken Dobutsu. 24(3), 89-94 (1975).
64. Zhang, S.H., Reddick, R.L., Piedrahita, J.A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258(5081), 468-471 (1992).
65. Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71(2), 343-353 (1992).
66. van Royen, N. et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc. Res. 57(1), 178-185 (2003).